Future Directions

English

IDF Guide to National Diabetes Programmes - new needs, new approach

We live in difficult but very exciting times: IDF has never been better organized or more powerful in its influence on global health policy at the highest level. The 2006 UN Resolution on Diabetes and the central role of IDF in bringing about the UN General Assembly decision in May this year to hold a UN Summit on Non-Communicable Diseases in September 2011 are proof of IDF’s effectiveness on the world stage.

Mobilizing on women and diabetes for global development

For three decades, ambitious commitments have been made at the global level to promote gender equality and empower women. But the translation into action of the commitments pledged in the Convention of the Elimination of All Forms of Discrimination Against Women, the Beijing Platform for Action and the Millennium Development Goals has been less impressive. Inequality between women and men and girls and boys remains pervasive, particularly in lowand middle-income countries.

IDF and the global NCD alliance: united for health and development

Non-communicable diseases, including diabetes, heart disease and cancers, cause 8 million premature deaths every year in low- and middle-income countries. The World Health Organization estimates that global deaths from these diseases will continue to rise over the next 10 years, with the African region expected to see the highest relative increase (27%). An increasing body of evidence shows that the human and financial impact of disease is undermining the achievement of the Millennium Development Goals.

Who's who in the global NCD alliance?

The global community is waking up to the potentially calamitous impact across all regions of diabetes and other non-communicable diseases (NCDs). The numbers are alarming. In 2005, chronic diseases, including cardiovascular disease, diabetes and cancers, accounted for 60% of deaths worldwide and almost half of the global burden of disease. Today, cardiovascular disease is the world's number one cause of mortality: 17 million deaths each year. The number of people with diabetes is set to rise from the current 238 million to 440 million by 2030.

The untold burden of the non-communicable disease epidemic

The recent Global Risks 2010 report issued by the World Economic Forum identifies chronic non-communicable diseases (NCDs) as one of the most important threats to the world’s agenda and a severe risk for global economic loss. NCDs, including diabetes, cardiovascular and respiratory diseases and cancer, are already extraordinarily costly to governments and the private sector, crowding out essential monies for needed government services and reducing profits.

This is your IDF - looking back, moving forward

The International Diabetes Federation (IDF) has led the global diabetes community for 60 years. Founded in Amsterdam, Holland, on 23 September 1950, IDF spent some years in London, UK, before setting up headquarters at its current location in Brussels, Belgium. It has developed into an umbrella organization of around 200 national diabetes associations, representing the interests of the increasing number of people with diabetes and those at risk.

The endocannabinoid system: linking body weight, metabolic disorders and tobacco dependence

Treatment with the newly developed drug rimonabant has been found to help to reduce body weight and improve cardiovascular and metabolic risk factors. It has also been shown to help smokers to stop using tobacco without the weight gain often associated with cessation. Beat Lutz reports on the recently discovered body system that links obesity, metabolic disorders and smoking, and the potential of rimonabant as a therapeutic option to tackle these multiple cardiovascular risk factors.

The standardization of glycated haemoglobin: is it desirable?

The measurement of glycated haemoglobin (as HbA1c ) is central to diabetes care. This is the measure by which health-care providers can relate blood glucose control to the risk of complications, such as eye damage or kidney failure. However, a lack of standardization in the methods used to measure glycated haemoglobin has produced wide variations among results and is among the current

Diabetes 'vaccines': can an injection prevent diabetes?

Since the first vaccine, when Edward Jenner in England used an extract of cow pox to prevent small pox, vaccines have become a part of most people’s life. Many millions of people have received a vaccine of some kind – in most cases, many

Diabetes after transplantation: revised guidelines target early treatment

People who have a kidney, liver or heart transplant are at high risk of developing diabetes. This can lead to cardiovascular disease and the rejection of the transplant. Factors such as age, weight and family history can increase the risk of new-onset diabetes after transplantation. Importantly, drugs that suppress the immune system and prevent transplant rejection also play a key role. In December 2003, an international panel of experts in transplantation and diabetes met to update the existing guidelines for the management of new-onset diabetes after

Pages